US Bancorp’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-3,668
| Closed | -$107K | – | 3752 |
|
|
2017
Q3 | $107K | Sell |
3,668
-3,093
| -46% | -$86.6K | ﹤0.01% | 2199 |
|
|
2017
Q2 | $177K | Sell |
6,761
-360
| -5% | -$8.85K | ﹤0.01% | 1904 |
|
|
2017
Q1 | $167K | Buy |
7,121
+2,081
| +41% | +$51.4K | ﹤0.01% | 1904 |
|
|
2016
Q4 | $127K | Buy |
5,040
+3,986
| +378% | +$101K | ﹤0.01% | 2004 |
|
|
2016
Q3 | $30K | Sell |
1,054
-143
| -12% | -$3.67K | ﹤0.01% | 2680 |
|
|
2016
Q2 | $30K | Buy |
1,197
+197
| +20% | +$4.89K | ﹤0.01% | 2646 |
|
|
2016
Q1 | $22K | Sell |
1,000
-110
| -10% | -$2.93K | ﹤0.01% | 2729 |
|
|
2015
Q4 | $39K | Buy |
1,110
+110
| +11% | +$3.45K | ﹤0.01% | 2557 |
|
|
2015
Q3 | $28K | Hold |
1,000
| – | – | ﹤0.01% | 2731 |
|
|
2015
Q2 | $33K | Hold |
1,000
| – | – | ﹤0.01% | 2747 |
|
|
2015
Q1 | $28K | Buy |
1,000
+984
| +6,150% | +$24.5K | ﹤0.01% | 2821 |
|
|
2014
Q4 | $0 | Hold |
16
| – | – | ﹤0.01% | 3682 |
|
|
2014
Q3 | $0 | Hold |
16
| – | – | ﹤0.01% | 3620 |
|
|
2014
Q2 | $0 | Hold |
16
| – | – | ﹤0.01% | 3612 |
|
|
2014
Q1 | $0 | Buy |
+16
| New | +$393 | ﹤0.01% | 3591 |
|
US Bancorp's PMC Position: Q4 2017 in Review
US Bancorp sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 3,668 shares — an estimated $107K sold.
US Bancorp first reported a position in PMC in Q1 2014 and held it in 15 quarters. The position peaked at $177K in Q2 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- US Bancorp reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- US Bancorp sold 3,668 PharMerica Corporation shares in Q4 2017, an estimated $107K.
- US Bancorp first reported a position in PharMerica Corporation in Q1 2014 and held it in 15 quarters.
- US Bancorp's PharMerica Corporation position peaked at $177K in Q2 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on US Bancorp's 13F filing for Q4 2017, filed 2 Feb 2018.